Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Fundracer B.V., founded by René Wiertz, Andy Ording, and Gérard Vroomen, is based in the Netherlands and specializes in the micro-mobility sector. The firm focuses on early-stage investments, particularly in North America and Europe, with a portfolio of seven companies. Their founders bring extensive experience in entrepreneurship and mergers and acquisitions to the table.
Fundracer primarily invests in early-stage companies within the micro-mobility and cycling sectors, targeting safety, zero-emission transport, and performance. They provide capital ranging from pre-seed to seed+ stages, along with strategic support in go-to-market strategies, product development, and operational scaling.
Notable companies in Fundracer's portfolio include Aerobag, a lightweight airbag system for cyclists; ReTyre, which creates eco-friendly tires from algae; Luna, an AI-powered safety video technology; Blubrake, known for advanced ABS technology for two-wheel vehicles; Newton-Rider, a fashionable and foldable commuting helmet; Specter, a high-performance carbon speed pedelec; and Bo, a stand-up scooter for commuting and leisure.
Submit your pitch through their form at fundracer.capital.
Yes, Fundracer often leads investment rounds, particularly in the pre-seed and seed stages, to help shape the direction of their portfolio companies.
Fundracer is open to follow-on investments, especially for companies that demonstrate strong growth potential and align with their focus on micro-mobility.
Specific details about the fund size are not disclosed, but Fundracer actively invests in early-stage companies within its targeted sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.